HOWL EPS Estimates
Werewolf Therapeutics, Inc.
$0.97
-$0.02(-1.53%)
55
Overall
60
Value
83
Tech
23
Quality
Market Cap
$47.63M
Volume
11.95K
52W Range
$0.27 - $1.83
Target Price
$4.67
HOWL EPS estimates: the consensus estimate for Werewolf Therapeutics, Inc.'s current fiscal year is -$0.89 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
HOWL EPS Estimates
- EPS estimate, current year
- $-0.89
- EPS estimate, next year
- $-0.59
- EPS growth, 3-year
- +10.80%
| Fiscal year | EPS |
|---|---|
| 2025 | $-1.32 |
| 2024 | $-1.63 |
| 2023 | $-1.05 |
| 2022 | $-1.86 |
| 2021 | $-10.94 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | HOWL | $0.97 | -1.5% | 11.95K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Werewolf Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW